E.E. Geduld’s Echo Therapeutics ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-25,000
Closed -$39K – 238
2015
Q3
$39K Hold
25,000
– – 0.04% 160
2015
Q2
$43K Hold
25,000
– – 0.03% 244
2015
Q1
$53K Hold
25,000
– – 0.04% 222
2014
Q4
$34K Hold
25,000
– – 0.02% 214
2014
Q3
$21K Hold
25,000
– – 0.01% 218
2014
Q2
$57K Sell
25,000
-25,000
-50% -$62.1K 0.04% 247
2014
Q1
$150K Hold
50,000
– – 0.08% 200
2013
Q4
$157K Hold
50,000
– – 0.08% 217
2013
Q3
$138K Sell
50,000
-15,000
-23% -$40.6K 0.08% 202
2013
Q2
$162K Hold
65,000
– – 0.12% 174

Other funds holding ECTE

E.E. Geduld's ECTE Position: Q4 2015 in Review

E.E. Geduld sold out of Echo Therapeutics (ECTE) in Q4 2015, closing a stake of 25,000 shares — an estimated $39K sold.

E.E. Geduld first reported a position in ECTE in Q2 2013 and held it in 10 quarters. The position peaked at $162K in Q2 2013. 18 funds tracked by Wall St. Rank hold ECTE as of Q4 2015.

  • E.E. Geduld reported no remaining Echo Therapeutics position as of Q4 2015 after selling out during the quarter.
  • E.E. Geduld sold 25,000 Echo Therapeutics shares in Q4 2015, an estimated $39K.
  • E.E. Geduld first reported a position in Echo Therapeutics in Q2 2013 and held it in 10 quarters.
  • E.E. Geduld's Echo Therapeutics position peaked at $162K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held Echo Therapeutics as of Q4 2015.

Based on E.E. Geduld's 13F filing for Q4 2015, filed 2 Feb 2016.